TIFFANY FELDER: Open Payments
NPI 1407381478 · PAPILLION, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 23 payments from 18 companies in 2025. Trend: 2023 $864 · 2024 $849 · 2025 $709
Food & beverage: $609Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $161 |
| ABBVIE INC. | 4 | $146 |
| Adaptive Biotechnologies Corporation | 1 | $113 |
| TerSera Therapeutics LLC | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $25 |
| pharmaand GmbH | 1 | $24 |
| TOLMAR, INC. | 1 | $24 |
| Exelixis Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: RYBREVANT, VENCLEXTA, clonoSEQ, Rubraca, EPKINLY, Xermelo, Enhertu, CABOMETYX.
Industry payments across NE — which companies pay providers there.
